Charge heterogeneity of therapeutic monoclonal antibodies by different cIEF systems: views on the current situation

Alessandro Ascionea National Centre for the Control and Evaluation of Medicines, Istituto Superiore di Sanità, Rome, ItalyCorrespondence[email protected]

https://orcid.org/0000-0002-7208-4122 View further author information

Marcello Belfioreb National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, ItalyView further author information

Jaana Vesterinenc Laboratory Department, Finnish Medicines Agency, Helsinki, FinlandView further author information

Mihaela Budad European Pharmacopoeia Department, European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, Strasbourg, FranceView further author information

Wolf Holtkampe Section IMG 3 “Product Testing of Immunological Biomedicines”, Paul-Ehrlich-Institut, Langen, GermanyView further author information

Francesca Luciania National Centre for the Control and Evaluation of Medicines, Istituto Superiore di Sanità, Rome, ItalyView further author information

Charge heterogeneity of therapeutic monoclonal antibodies by different cIEF systems: views on the current situation

Supplementary Information_Ascione et al_FINAL.docx

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Charge heterogeneity of therapeutic monoclonal antibodies by different cIEF systems: views on the current situation

Supplementary Information_Ascione et al_FINAL.docx

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date